Picture of Galderma AG logo

GALD Galderma AG News Story

0.000.00%
ch flag iconLast trade - 00:00
Consumer DefensivesAdventurousLarge CapHigh Flyer

Swiss stocks - Factors to watch on May 28

ZURICH/GDANSK, May 28 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Wednesday:

SNB SNBN.S

Swiss inflation could enter negative territory in the coming months, Swiss National Bank Chairman Martin Schlegel said on Tuesday.

SWISS RE SRENH.S

Swiss Re Corporate Solutions’ Katie McGrath has said that the U.S. property insurance market needs to catch up with the sophistication of risk managers to meet their needs over the next five years, and also explained the rationale behind her company’s move towards a market units structure.

GALDERMA GALD.S

Galderma intends to buy back 2.4 million shares in context of accelerated bookbuild offering, bookrunner says orders below CHF 97.75 per share risk missing, secondary ABB books close.

KUEHNE + NAGEL KNIN.S

K+N partners with Natilus to bring blended-wing-body aircraft to commercial air freight.

IDORSIA IDIA.S

Dr. David E. Shaw reports stake of 3.124% in Idorsia.

COMPANY STATEMENTS

* Dottikon Es  DESN.S says it generated FY net sales of 385.2 million Swiss francs, an increase of 18.1% year-on-year.

ECONOMY

Swiss Investor Sentiment due at 0800 GMT.

SNB Dollar Auction due at 0900 GMT.

 (Reporting by Zurich newsroom and Gdansk newsroom)

 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))

For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g

FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES

Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E

SPEED GUIDES:  EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS

Recent news on Galderma AG

See all news